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Background: Labial salivary gland biopsy (LSGB) is the most important diagnostic tool for the diagnosis of Sjögren’s
syndrome (SS), but its diagnostic value is rarely studied. This study assessed the sensibility and specificity of LSGB, and
the clinical profiles of patients who were referred for biopsy.
Methods: Retrospective analysis of the histopathological reports from LSGB and medical report data from patients who
underwent LSGB between 2008 and 2011 was conducted.
Results: About 290 biopsies were performed and 74 were excluded due to insufficient clinical data. Of the 216 patients,
0.46% was carrier of hepatitis C virus, 30.1% had primary SS (pSS), and 8.8% had secondary SS (sSS). Of the samples, 94.3%
presented dryness symptoms, 51.6% experienced dryness only, 42.7% had systemic manifestations, and 66.9% presented
low unstimulated salivary flow and/or Schirmer’s test. LSGB was necessary in 67.6% to confirm the presence of SS based
on the American-European Consensus Group 2002 criteria (AECG). Based on specialist’s opinion, sensibility level was
86.57%, and specificity was 97.43%. Positive predictive value (PPV) was 95%, and negative predictive value (NPV) was
92.6%. Determined accuracy was 93.3%. Concordance (kappa coefficient) of LSGB and specialist’s opinion was 0.851, and
LSGB with AECG criteria was 0.806. Of the 98 patients referred with fibromyalgia and dryness, 36.7% had SS and LSBG
focus score of≥ 1. Patients with SS were older, and showed more severe lachrymal and salivary dysfunctions, greater
frequency of fibromyalgia, anti-nuclear antibodies (ANA), anti-SSA-Ro, and anti-SSB-La.
Conclusions: Labial salivary gland biopsy has high sensibility, specificity, positive and negative predictive values for
diagnosis of pSS. In the clinical practice, it is useful, especially for those patients with glandular dysfunctions and
negative antibodies.
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Sjögren’s syndrome (SS) is considered the second most
common rheumatic autoimmune disease affecting be-
tween 0.05% and 0.4% of the world population [1-3]. In
spite of being relatively common, it is still rarely diag-
nosed because of a pleomorphic presentation varying
from mild cases of dryness, fatigue, and pain confound-
ing with fibromyalgia (FM) to severe systemic cases
similar to rheumatoid arthritis (RA) and systemic lupus* Correspondence: val.valim@gmail.com
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unless otherwise stated.erythematosus (SLE). It also has a wide differential diag-
nosis including infection by hepatitis C and HIV, hyper
IgG4 syndrome, sarcoidosis, and lymphoma [4].
The difficulty in diagnosis is reflected on continuous
review attempts of the 7 classification criteria that have
been created in the past 25 years [5]. However, histo-
logical analysis of labial salivary gland biopsy (LSGB) is
mostly a method of great importance according to the
American-European Group Consensus (AEGC) criteria
[6] and the criteria proposed by the American College
Rheumatology in 2012 (ACR 2012) [7]. The indication
for the LSGB performance has not been well established
yet in clinical practice, and few published studies have
evaluated the sensibility and specificity of LSGB in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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with and without pSS not using LSGB findings and clinical
re-evaluation (specialist’s opinion) [9,10]. Other studies
have used AECG, but it presents bias because LSGB is
part of the AECG criteria [11-17]. A recent systematic re-
view indicated a lack of information about the diagnostic
value of MSGB [8].
The main objective of this study was to evaluate the
biopsy accuracy based on suspected cases of SS referred
to LSGB. Also, we described the clinical characteristics
and glandular dysfunctions of patients referred to biopsy,
comparing patients with pSS and nonspecific dryness
syndrome.
Methods
This was a retrospective study including all patients
from the Rheumatology Unit of the University Hospital
of the Federal University of Espírito Santo (HUCAM/
UFES/EBSERH), above 18 years old, and referred for
LSGB to investigate SS between March 2008 and March
2011. All recorded histological reports of LSGB in that
period were assessed.
Labial salivary gland biopsy technique and histological
parameters
LSGBs were performed by 2 experienced rheumatolo-
gists, using linear incision [18] described as follows.
Lidocaíne 2% with 1 ml of epinephrine was injected in
the mentonian foramen to block nerve. The lower lip
was everted to find a normal and healthy area, usually
the left side when possible. The best site was chosen by
palpation to find glands. A horizontal incision as min-
imal as possible, usually less than 1 cm, was made over
the gland by scalpel (blade 3). Simultaneously, the out-
side lip was compressed to improve hemostasia. Glands
usually bulged from the wound. The wounds were
moved and rolled to expose the glands better. Glands
(4–8) were collected carefully to avoid harming the ves-
sels and nerves. One to three surgical stitches using silk
or resorbable suture were necessary.
Histopathological analysis was performed by 2 experi-
enced pathologists. They scored the focus numbers and
have considered compatibility with SS if the focus score
is ≥ 1 (“positive biopsy”), based on the classification de-
scribed previously [18-20].
Dryness symptoms and glandular dysfunction
Concurrently with biopsy, patients performed Schirmer’s
test I (without anesthesia) (ST) and unstimulated saliv-
ary flow (USF). Glandular dysfunction was defined if ST
was < 5 mm in 5 minutes using standardized sterilized
test strips (Ophtalmos, São Paulo, Brazil) and/or USF
was ≤ 1.5 ml/min measured in 15 minutes. Patients wererecommended to have breakfast without coffee or choc-
olate. All measures were done between 8 a.m. and 9 a.m.
Just before glandular function evaluation, patients
answered some questions to identify dryness symptoms [6]:
1. Have you had daily, persistent, troublesome dry eyes
for more than 3 months?
2. Do you have a recurrent sensation of sand or gravel
in the eyes?
3. Do you use tear substitutes more than 3 times a
day?
4. Have you had a daily feeling of dry mouth for more
than 3 months?
5. Have you had recurrently or persistently swollen
salivary glands as an adult?
6. Do you frequently drink liquids to aid in swallowing
dry food?Clinical parameters
Demographic, autoantibodies, clinical manifestations,
comorbidities, and reasons for being referred for LSGB
were obtained through medical reports. The autoanti-
bodies evaluated were antinuclear antibody (ANA) using
indirect immunofluorescence, rheumatoid factor (RF)
measured by turbidimetry, and anti-SSA-Ro and anti-
SSB-La using hemagglutination.
Patients were classified as having SS according to the
AECG criteria and specialist’s opinion. The specialist’s
opinion was maiden considering the diagnosis described
in the medical report and re-evaluation by 2 specialists.Statistical analysis and ethical aspects
Patients with insufficient data for SS diagnosis or with-
drawers were not included in the analysis.
Demographics, reasons for biopsy indication, clinical
manifestation, and glandular dysfunction of the referred
patients for LSGB were described.
Sensibility, specificity, positive predictive value (PPV),
and negative predictive value (NPV) of LSGB were cal-
culated with the specialist’s opinion serving as the gold-
standard.
Patients were also classified according the AECG criteria
[6], and comparisons between patients with primary SS
and nonspecific dryness syndrome were evaluated in
terms of demographics, comorbidities, glandular dysfunc-
tion, and presence of auto-antibodies.
Concordance levels between LSGB and specialist’s
opinion, and LSGB and AECG were calculated by the
Kappa coefficient.
The collected data were analyzed and processed using
the IBM SPSS Statistical Package for Social Sciences version
19 (IBM, Armonk, New York, USA). Mann–Whitney and
Z (Chi-square) tests were used for the comparison between
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when the p value is < 0.05.
This Project was approved by the Ethics Committee in
Research of the Health Science Center from the Federal
University of Espírito Santo in October 26, 2011 (proto-
col number 241/11). Written informed consent for par-
ticipation in the study were not required by Ethics
Committee because it was a retrospective study, and all
procedures were routine for SS diagnosis. We have ob-
tained a written consent by Hospital director to access
all registered information in the hospital system.
Results
Two-hundred-ninety (290) individuals underwent LSGB
during the period to investigate SS. Seventy-four patients
(74) were excluded due to lack of clinical information.
Demographic and clinical characteristics of the 216 in-
cluded individuals are detailed in Table 1. All biopsies
had sufficient salivary gland samples (≥4 mm2), and only
7 cases < of 8 mm2. The average was 12.52 ± 5.30 mm2.
Dryness was the reason to investigate SS in 94.3% of
the samples. About 51.6% had dryness only, and 42.7%
had associated extra-glandular manifestations. Only 5.5%
of the patients were referred because of extra-glandular
manifestation without dryness, with 2 having polyneur-
opathy, 1 had positive ANA and polyarthralgia, 3 had
positive ANA and polyarthritis, 1 had central nervous
system vasculitis, 1 had recurrent parotiditis, 1 had
rheumatic fever with mitral regurgitation, 1 had scleritis,
1 had pancytopenia, 1 had polyarthritis that was defined
as rheumatoid arthritis afterwards. Of the patients re-
ferred for biopsy, 66.9% (N = 144) showed ST of < 5 mm
and/or USF of ≤ 1.5 ml/min.
To analyze biopsy accuracy for primary SS diagnosis,
we included 183 patients. Nineteen (19) with secondaryTable 1 Demographic and clinical characteristics of the
suspected cases referred for labial salivary gland biopsy
Parameters N = 216
Age (years) 47.7 ± 12.5
Gender (Women) 188 (87%)
Dryness symptoms (only) 111 (51.4%)
Dryness and systemic symptoms 92 (42.6%)
Systemic symptoms (only) 12 (5.55%)
Virus C Hepatitis 1 (0.45%)
Unstimulated salivary flow (<0.1 ml/min) 119 (55.09%)
Schirmer test I (≤5 mm) 103 (47.68%)
Anti-SSA and/or anti-SSB 36 (16.66%)
ANA 100 (46.29%)
Rheumatoid Factor (latex) 40 (18.51%)
Focal Sialoadenitis (focus score≥ 1) 79 (36.57%)
ANA = antinuclear antibodies.SS and 13 without the specialist’s opinion in the medical
report were excluded from a total of 216. Biopsy was
positive (≥1 focus score) in 61 patients (58 having SS ac-
cording to specialist’s opinion, and 3 not having SS). Bi-
opsy was negative (<1 focus score) in 122 (9 having SS
according to specialists opinion and 113 not having SS).
Sensibility level was 86.57%, and specificity was 97.43%.
The positive predictive value (PPV) was 95%, and the
negative predictive value (NPV) was 92.6%. Determined
accuracy level was 93.3%.
Patients were also classified according to the AECG
(Figure 1). Concordance of LSGB was high and signifi-
cant (p < 0.05) with both, but higher with specialist’s
opinion (kappa = 0.851) than AECG criteria (kappa = 0.806).
LSGB was necessary in 67.6% (n = 44) to fulfill the
AECG criteria for SS. The results of the investigation
flow for the diagnosis of SS is shown in Figure 2. The
combination of glandular dysfunction and positive ser-
ology (anti-SSA-Ro and/or anti-SSB-La) seemed to be
useful in identifying positive biopsy and SS diagnosis.
Most patients (N = 14, 70%) with ST of <5 mm/min
and/or USF of ≤1.5 ml/min had LSGB compatible with
SS and met the AECG criteria for pSS. On the other
hand, great majority (N = 23, 85.1%) of patients with no
lachrymal and salivary dysfunction, besides negative
antibody, had LSGB focus score of < 1, and no one ful-
filled the AECG criteria for SS.
In spite of being common autoantibodies in SS, the
presence of ANA ≥ 1/320 and positive RF concomitantly
with negative anti-SSA-Ro and anti-SSB-La occurred
only in 2.3% (n = 5) of the patients. These patients failed
to fulfill the AECG criteria. Two (2) showed LSGB focus
score of ≥ 1 and diagnosis of SS based on the specialist’s
opinion; 3 showed both biopsy result and specialist’s
opinion negative for SS.
Comparing patients with pSS (AECG) and nonspecific
dryness syndrome, the pSS patients were older, pre-
sented more severe salivary and lachrymal dysfunction,
more frequency of ANA antibodies, anti-SSA-Ro, and
anti-SSB-La; and had more systemic manifestations.
Fibromyalgia was the most prevalent comorbidity among
patients with pSS. Of the 98 patients with fibromyalgia
and who were referred because of sicca syndrome, 36.7%
(n = 36) displayed LSGB compatible with SS (focus score
of ≥1) (Table 2).
Discussion
This study was about the relevance of LSGB for diagno-
sis of pSS in real life, analyzing a cohort of patients re-
ferred for biopsy. Only a few published studies have
evaluated the diagnostic usefulness of MSGB in pSS [8].
Most studies were on retrospective analysis, and evalu-
ation of biopsy accuracy was not the main objective.
Our study compared LSGB results with a re-evaluation
Figure 1 Flow chart study. pSS: primary Sjögren’s syndrome according to AECG, sSS: secondary Sjögren’s syndrome according to AECG, 8 SLE:
Systemic Lupus Erythematosus, 6 RA: Rheumatoid Arthritis, 3 Overlap (SSc: Systemic Sclerosis, APS: Antiphospholid Syndrome, SS: Sjögren’s syndrome).
Figure 2 Diagnostic flow of suspected patients of Sjögren’s syndrome. USF: unstimulated salivary flow; ST: Schirmer test; anti-SSA/SSB +: anti-SSA
and/or anti-SSB positive; anti-SSA/SSB -: anti-SSA and/or anti-SSB. negative; Biopsy +: score focus≥ 1; Biopsy -: focus score < 1; no SS: no Sjögren’s. syndrome;
pSS: primary Sjögren’s syndrome according to the American European. Consensus Group 2002.
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Table 2 Clinical characteristics of patients with primary Sjögren’s syndrome and nonspecific dryness syndrome
Primary Sjögren’s syndrome (AECG) n = 65 Nonspecific dryness syndrome n = 132 *p-value
Age (years) 49.6 ± 12 45.8 ± 12.9 0.02
Gender (Women) 65 (98.5%) 123 (94.6%) 0.36
Oral symptoms 60 (90.9%) 95 (85.6%) 0.42
Ocular symptoms 61 (92.4%) 90 (81.1%) 0.07
Salivary flow (<0.1 ml/min) 53 (80.3%) 51 (46.4%) 0.00
Schirmer (≤5 mm) 42 (70.0%) 50 (56.2%) 0.13
Focal Sialoadenitis (focus score≥ 1) 59 (89.4%) 7 (5.4%) 0.00
Anti-SSA and/or anti-SSB 21 (32.3%) 6 (6.2%) 0.00
Rheumatoid Factor (látex) 14 (25.9%) 22 (21.0%) 0.62
ANA 39 (66.1%) 44 (40.0%) 0.00
Fibromyalgia 41 (63%) 57 (43.6%) 0.01
Hypertension 26 (39.4%) 38 (29.2%) 0.20
Dyslipidemia 10 (15.2%) 12 (9.2%) 0.31
Diabetes Mellitus 4 (6.1%) 13 (10.0%) 0.52
Depression 8 (12.1%) 12 (9.2%) 0.70
Hyperthyroidism, Graves Disease 8 (12.1%) 9 (6.9%) 0.34
Osteoporosis/Osteopenia 8 (12.1%) 9 (6.9%) 0.34
Osteoarthritis 20 (30.3%) 28 (21.5%) 0.24
Neoplasia 5 (7.6%) 2 (1.5%) 0.08
*Chi-square Test.
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and accuracy were found. The only study with compar-
able methodology also found high sensibility (85.7%),
specificity (89.7%), PPV (85.7%) and NPV (89.7%) [9]. In
others studies, sensibility and specificity of LSGB ranged
from 63.5% to 93.7% and from 61.2% to 100%, respect-
ively [8]. It seems that specificity and PPV are high, and
sensitivity is variable depending on the profile of the
studied patients.
The diagnosis of pSS is not easy, and it is guided by a
combination of clinical manifestations, glandular dys-
function, laboratory exams, and MSGB. At present,
MSGB has a major role being included in the AECG
2002 [6] and ACR 2012 criteria [8]. It is also important
for the prognosis of SS by giving information about sub-
sets of patients [21]. However, it is an invasive method,
and when to indicate in the clinical practice remains to
be the difficult decision to make. There is no algorithm
or any recommendation about that. Ultrasound is being
evaluated to be included in a set of criteria for diagnosis
[22-24]. In spite of being a promising tool for diagnosis
and prognosis, and having sensibility comparable to
scintigraphy and sialography, it is probable that the US
could not substitute biopsy for all patients [16,22-24].
We have analyzed the reasons of indicating and the
profile of suspected patients referred for MSGB. Dryness
occurred in SS in 75.7% to 96.7% [25-27], and it was the
most common reason for indicating biopsy in our cohort.However, almost half of the patients had extra-glandular
symptoms. In our study there were some patients that had
systemic symptoms only. In spite of not being so common,
SS should be considered without dryness symptoms, in
special in patients with peripheral neuropathy, parotiditis,
arthritis, hematological manifestations, or both positive RF
and ANA. Another study reported the same extra-
glandular manifestation in patients referred for biopsy [17].
It appears that glandular dysfunction measured by
USF and ST was a good screening for the diagnosis.
Most patients with glandular dysfunction and positive
serology (positive anti-SSA-Ro and/or anti-SSB-La) had
positive biopsy (≥1 focus score), and those with normal
glandular function and negative serology had negative
biopsy. LSGB was necessary to define diagnosis in those
patients with glandular dysfunction and negative ser-
ology. Based on our results, patients with glandular dys-
function and incomplete AECG criteria should be
submitted to LSGB, as it is the only way to discriminate
patients with or without SS. Consensus recommendation
to standardize an investigation algorithm might contrib-
ute in increasing the number of diagnosed cases.
In our cohort referred for LSGB, we found 38.9% of SS
(30.1% pSS and 8.8% sSS). The frequency of SS in sus-
pected cases using the AECG criteria varied from 32.8%
to 79.2% [7,9,28]. Unfortunately, we could not perform a
comparison to ACR 2012 criteria because data were col-
lected between 2008 and 2011. Also, we have used just
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ple and it can be performed by a rheumatologist. In
our clinic, patients are referred to an ophthalmologist
only when SS diagnosis is confirmed or when there is
a suspected case not fulfilling the criteria. Not in-
cluding Schirmer’s test in criteria setting is a disad-
vantage because it is very easy, cheap, and also has
sensibility, specificity, and accuracy comparable to
other methods (29).
The frequencies of ANA and RF found in our study
were 20% and 66.1%, respectively. These rates were simi-
lar to results found in previous studies [14,27-30]. The
presence of FAN and RF was included in the diagnosis
criteria suggested by Fox et al., in 1986 [30], made part
of the preliminary criteria proposed by Vitali et al., in
1993 [31], and was inserted again in the criteria pro-
posed by ACR 2012. In our study, concomitant presence
of ANA ≥ 1/320 and positive RF in patients without anti-
SSA-Ro and anti-SSB-La antibodies occurred in only
2.3% of the patients.
Comparing patients with dryness with or without SS
in our study, we noticed a high prevalence of FM in both
pSS (63%) and non-SS (43.8%) groups. Moreover, 36.7%
of patients with fibromyalgia referred for LSGB because
dryness symptoms displayed LSGB with focus score of
≥ 1 and they met the AECG criteria for SS. These data
suggest that fibromyalgia is a trick, as differentiating it
from diffuse muscle skeletal pain and fatigue of SS is not
possible, thus underestimating FM diagnosis in SS. On
the other hand, dryness and fatigue are common symp-
toms in FM patients. Our data suggest that SS should be
investigated in patients with FM and dryness.
We did not have any data about complications in our
patients. This information was not collected from all
patients. Some complications like pain, bruising, bleed-
ing, and wound infection have been reported, but they
are rare. The main LSGB complication is lip numbness,
but permanent neurological complication brought
about by the linear incision technique occurs only in
1.4% of the patients [32]. From our perspective and not
based on data, it seems to be a safe technique when
performed by experienced professionals. In our hos-
pital, rheumatologists do biopsy and discuss weekly the
results with pathologists. Good connections between
rheumatologists, pathologists, and professionals doing bi-
opsy, can minimize the risks and optimize the quality and
size of the material.
This study was a retrospective study that could result
in having bias. For example, in the routine, patients
usually are evaluated according to the classification cri-
teria 2002. Also, a specialist’s opinion was considered
the gold-standard and biopsy results were considered
come up with a final diagnosis. Future prospective
studies comparing with ultrasound will be useful.Conclusions
Labial salivary gland biopsy has high sensibility, specifi-
city, and positive and negative predictive values. In the
clinical practice, it is useful especially for those patients
with glandular dysfunctions and negative antibodies.
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